Picture of Fresenius SE & Co KGaA logo

FRE Fresenius SE & Co KGaA News Story

0.000.00%
de flag iconLast trade - 00:00
HealthcareBalancedLarge CapNeutral

REG - Deutsche Bank AG FF - Post Stabilisation Notice -Fresenius EUR 3yr & 8yr

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220615:nRSO0442Pa&default-theme=true

RNS Number : 0442P  Deutsche Bank AG, Frankfurt  15 June 2022

15(th) June 2022

 

 

Not for distribution, directly or indirectly, in or into the United States or

any jurisdiction in which such distribution would be unlawful.

 

Fresenius SE & Co. KGaA

 (the Issuer)

 

Post-stabilisation Period Announcement

 

Further to the pre-stabilisation period announcement dated 17(th) May 2022,
Deutsche Bank AG, Frankfurt (contact: Debt Syndicate, Phone No. +44 207 547
6885) hereby gives notice that no stabilisation (within the meaning of Article
3.2(d) of the Market Abuse Regulation (EU/596/2014)), and also as it forms
part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018
was undertaken by the Stabilisation Manager(s) named below in relation to the
offer of the following securities.

 

 

 The Securities:

 Issuer:                    Fresenius SE & Co. KGaA

 Guarantor (if any):

 Aggregate nominal amount:  EUR 1.3bn

 Description:               Fresenius EUR 750M 1.875% 3yr & EUR 550m 2.875% 8yr

 ISIN Code:                 XS2482872418 | XS2482872251

 Issue/reoffer price:       99.948 | 98.844

 Spread over benchmark:     OBL 0% Apr-25 + 144bps | DBR 0% Feb-30 + 213.6bps

 Stabilisation:

 Stabilising Manager(s):    BofA Securities, Credit Suisse, Deutsche Bank, Société Générale

 

This announcement is for information purposes only and does not constitute an
invitation or offer to underwrite, subscribe for or otherwise acquire or
dispose of any securities of the Issuer in any jurisdiction.

 

This announcement is not an offer of securities for sale into the United
States. The securities referred to above have not been, and will not be,
registered under the United States Securities Act of 1933 and may not be
offered or sold in the United States absent registration or an exemption from
registration. There has not been and will not be a public offer of the
securities in the United States.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  STAEAKKSFFAAEFA

Recent news on Fresenius SE & Co KGaA

See all news